American lawyers seek $600 million on childrens Seroxat refund - but did they get it?

The drug was not officially sanctioned by US regulator the food and drug administration for use in under-18s. But doctors were allowed to use their own judgment, based on information letters sent by GSK. The lawsuit claims some of these letters omitted the negative information about the drug.




The class action lawsuit was filed in a Minnesota district court last month and is a federal case. The lead plaintiff, Nancy Gerdts, bought the drug for her 12-year-old son in August 2002 and is attempting to get her money back.



Because the law firm is still targeting the thousands of people who bought the drug, the amount the class action is seeking to recover is not yet known. Mr Dahlberg said he estimated the claim could be worth as much as $600m.



Class action lawsuits relating to drugs have been increasingly common in the US, particularly those involving serotonin reuptake inhibitors, which include Prozac and Seroxat
http://www.guardian.co.uk/business/2004/sep/06/medicineandhealth.mentalhealth